LA BioMed

27 articles about LA BioMed

• Vaping Causes Lung Damage in Just 3 Days of Use, New Study Says

  11/6/2019

  E-cigarette use, or vaping, can damage lungs in as little as three days of use, according to a new study from The Lundquist Institute and the University of Rochester.

• Los Angeles’ Most Advanced Life Science Co-Working Space Opens for Business, Welcomes Eight Innovative Startups

  9/12/2019

  The new biotech coworking space, BioLabs LA at The Lundquist, is ready to welcome innovative bioscience startups

• LA BioMed Scientists Developing a Vaccine to Protect Against Deadly Superbug

  8/6/2019

  Groundbreaking experiments have immunized mice against the infection caused by Candida auris

• LA BioMed-led Study Finds Low Fat Dietary Pattern Decreases Deaths from Breast Cancer

  5/15/2019

  Post-menopausal women on low-fat diets had materially better outcomes

• Hospital-acquired Antibiotic-resistant Fungal Infections Being Tackled by Torrance, CA Non-profit

  4/12/2019

  Researchers at LA BioMed in Torrance, CA have been working to create a therapeutic vaccine for 2 years to fight infections caused by Candida auris.

• Endari Is a Proven Safe and Effective Sickle Cell Treatment

  3/12/2019

  Product developed at LA BioMed is a safe, economical, available primary therapy

• LA BioMed Launches Unique Doctoral Program in Translational Research

  12/10/2018

  New Program Creates a Triple Threat: Graduates with Clinical, Business & Research Skills

• Pay Inequality Hits the Operating Room – LA BioMed Study Finds Female Docs Uncomfortable Pursuing Comparable Salaries to Men

  11/1/2018

  While male and female surgeons both work equally hard saving lives in the operating room, women in general surgery project earning significantly less than men.

• LA BioMed Launches Groundbreaking Study on Deadly Skin Infections 

  10/23/2018

  $5.3 million NIH grant will fund research on effective therapies for antibiotic-resistant strains 

• LA BioMed Leads Groundbreaking Studies on Deadly Infectious Disease 

  10/16/2018

  Two studies are part of broader effort to take aim at one of the world’s deadliest infections

• LA BioMed At Center of LA County Bioscience Summit 

  9/20/2018

  Dr. Meyer to lead panel of thought leaders capitalizing on region’s role as influential bioscience hub

• Disruptions and Future Trends Shaping Bio-Tech Industry Investments Reveal Los Angeles as New Node 

  9/17/2018

  Event Bolsters Los Angeles as a National Biotech Hub

• Bio-Tech Startups Highlight Groundbreaking Discoveries at LA BioMed’s Innovation Showcase

  9/5/2018

  The Latest Medical Innovations in Therapeutics, Diagnostics, and Medical Devices.

• LA BioMed Announces $50 Million Bond Sale to Benefit Future High-tech Construction

  8/29/2018

  Demand for organization’s first bond issue was more than twice the offering size.

• 

  August 10 Research Roundup: Type 2 Diabetes, Breast Cancer, Ebola and Koalas

  8/10/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

• Superbug May Soon Be Killed By LA Biomed Led Research Combating Deadly Drug-Resistant Bacteria

  8/9/2018

  A groundbreaking study by LA BioMed researchers shows promising results for a potential vaccine for deadly drug-resistant bacteria also known as superbugs.  

• Two Forms of Male Birth Control Are Closer to Reality Thanks to New Research

  8/2/2018

  LA BioMed announced the launch of two new male contraceptive studies.

• LA BioMed’s Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant

  6/21/2018

  NIH funded research led by Dr. Rie Sakai-Bizmark has potential to save the lives of hundreds of newborn babies annually.

• LA BioMed's Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant

  6/20/2018

  A researcher from LA BioMed has been awarded $688,013 in grant funding from the National Institutes of Health to improve newborn infant screening. The proposal by Rie Sakai-Bizmark, MD, PhD, MPH is entitled "Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation."

• LA BioMed helps drive LA County's ranking as national Top-10 BioPharma Cluster

  6/7/2018

  A new 78,000 SF research building and bioscience incubator are set to open in early 2019, further securing LA BioMed's contribution to biotech leadership in Southern California